G Patrick Lepore
Affiliations
- at Vyne Therapeutics Inc. (VYNE), 2025-01-16
- Director at Lannett Co Inc (LCI), 2022-11-14
- Director at Matinas Biopharma Holdings Inc. (MTNB), 2020-11-10
- Director at Pharmerica Corp (PMC), 2017-12-08
- Director at Innoviva Inc. (INVA), 2017-04-24
- Executive Chairman at Par Pharmaceutical Companies Inc. (PRX), 2012-10-02
Insider Trading: Purchases See All
Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
VYNE | $2.92 | 15,000 | $43,800.00 | 51,472 | 2025-01-15 | Filing |
VYNE | $3.91 | 13,000 | $50,778.00 | 36,472 | 2023-11-15 | Filing |
VYNE | $2.48 | 20,000 | $49,680.00 | 23,472 | 2023-03-20 | Filing |
LCI | $0.49 | 100,000 | $49,000.00 | 587,145 | 2022-11-10 | Filing |
LCI | $0.54 | 50,000 | $27,000.00 | 487,145 | 2022-05-16 | Filing |
Insider Trading: Sales See All
Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
PRX | $34.44 | 2,331 | $80,279.64 | 263,570 | 2011-05-09 | Filing |
PRX | $34.43 | 45 | $1,549.35 | 265,901 | 2011-05-09 | Filing |
PRX | $34.42 | 6,309 | $217,155.78 | 265,946 | 2011-05-09 | Filing |
PRX | $34.35 | 200 | $6,870.00 | 272,255 | 2011-05-09 | Filing |
PRX | $34.30 | 400 | $13,720.00 | 272,455 | 2011-05-09 | Filing |